Corbus Pharmaceuticals (CRBP) PT Lowered to $58 at RBC Capital
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $10.08 +3.28%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $58.00 (from $65.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR389 at Nomura/Instinet
- Wilmar International Ltd. (WIL:SP) (WLMIY) PT Raised to SGD3.70 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
